Amsterdam – Rheumatoid arthritis patients who are on standard methotrexate therapy may benefit from the addition of the biologic treatment, ENBREL* (etanercept), according to new data from a one-year, ...
ENBREL is also indicated in the treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate. ENBREL, alone or in combination with methotrexate, ...
(Reuters) - A federal appeals court on Wednesday upheld two patents for Amgen Inc's multibillion-dollar rheumatoid arthritis drug Enbrel, rejecting Novartis AG's effort to void the patents. In a 2-1 ...
Over Half of Xeljanz-Treated RA Patients Were Biologic Naive at Initiation, According to a New Report from BioTrends Research Group EXTON, Pa., Sept. 19, 2013 /PRNewswire/ -- BioTrends Research Group, ...
Surveyed Rheumatoid Arthritis Patients on Biologic Therapy Believe That the Benefits Outweigh the Risks for Available Biologics, with Enbrel Rating the Highest, According to a Recent BioTrends Report ...
SAN FRANCISCO -- Immunex Corp. will tell doctors its popular rheumatoid arthritis drug Enbrel can treat other joint and spinal disorders, part of a strategy to expand the market for Enbrel and keep it ...
Amgen and Pfizer Announce Results From the Largest Completed Clinical Trial of a Biologic Therapy in Adults with Moderately Active RA THOUSAND OAKS, Calif. and NEW YORK, Nov. 5, 2011 /PRNewswire/ -- ...
Sofusa is a drug delivery platform technology which delivers biologic therapies through the skin directly into the lymphatic system with potential to improve efficacy and safety and reduce the ...
May 17 (Reuters) - The U.S. Supreme Court on Monday dashed Novartis AG's NOVN.S hopes of launching a generic version of Amgen Inc's AMGN.O multibillion-dollar rheumatoid arthritis Enbrel, declining to ...
THOUSAND OAKS, Calif., November 12, 2006 -- Amgen (NASDAQ: AMGN) today announced that Enbrel? (etanercept) is the first biologic with published data to show improvements in multiple measures of ...
Instead of trying to promote its star rheumatoid arthritis drug, Enbrel, since the beginning of the year Immunex Corp. has been closely managing its tight supply of the drug. But that's about to ...